Watch a panel of experts discuss the practice-changing potential of ASCO GU 2021's top abstracts on the standard of care.
On February 13, 2021 LARVOL hosted an Oncology Panel to discuss the top abstracts during the ASCO-Genitourinary(ASCO-GU) Conference, held on February 11-13, 2021. Dr. Tian Zhang from Duke University served as the panel’s moderator while Drs. Petros Grivas from University of Washington, Neeraj Agarwal from University of Utah and Shilpa Gupta from Cleveland Clinic served on the panel.
Highlights of the panel discussion included enthusiasm for enfortumab vedotin for advanced urothelial carcinoma and for cabozantinib for metastatic papillary renal cell carcinoma as well as an in-depth discussion on the appropriate combination therapy for different subgroups within metastatic renal cell carcinoma. Please find the full discussion here:
LARVOL CONF makes your conference planning easy by providing complete coverage through comprehensive titles and abstracts planners.
Coincides with launch of first social listening and sentiment analysis platform allowing researchers and pharma developers to tune into the cancer conversation with verified oncologists on Twitter